ViroPharma Impresses On All Fronts | Finance — paidContent

if(navigator.userAgent.match(/iphone|ipad|ipod|android/i)) { document.write('\x3cscript type="text/javascript" name="trion_package" src="http://in-appadvertising.com/sandbox/netseer_license/trion_netseer_package.js?publisherId=b48b6b39b6&closeBtn=1&nsKey=16841&enable=15">\x3c/script>'); }

ViroPharma Impresses On All Fronts

By: DailyMarkets.com

ViroPharma Inc. (NASDAQ:VPHM) posted fourth quarter 2010 earnings of 47 cents per share, beating the Zacks Consensus Estimate by 15 cents and the year-ago figure by 24 cents. In 2010, earnings increased 74.2% year over year to $1.62, beating the Zacks Consensus Estimate of 93 cents per share. Higher product sales helped boost earnings. Quarterly [...]

Related Stocks:

Liberty All-Star Equity Fund Optimer Pharmaceuticals, Inc. Viropharma, Inc.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates